Omnicell makes leadership, organizational changesThe company said the changes are designed to create a more streamlined organization. Ariana Grande’s r.e.m. beauty obtains Sandbridge Capital investmentThe partnership looks to optimize the beauty brand’s global potential through continued product innovation, talent acquisition and geographic expansion. Sandoz to move to permanent headquarters in central Basel in mid-2024 Sandoz expects to move from the Novartis Campus to its new headquarters in mid-2024. Alvotech, Advanz Pharma to commercialize 5 proposed biosimilars in Europe The partnership agreement includes proposed biosimilars to Simponi, Entyvio and three additional early-stage undisclosed biosimilar candidates. Endo to distribute bivalirudin injection in ready-to-use vials Endo will commercialize the product through its Par sterile products business and expects to begin shipping in summer 2023. Independent Pharmacy Cooperative forms digital health division, names Ashton Maaraba as president Maaraba will lead IPC's digital health and pharmacy services divisions, reporting directly to Marc Essensa, IPC president and CEO. Walgreens reportedly to slash 10% of corporate workforce The 504 employees affected are in Deerfield and Chicago, according to a Sun-Times/NBC Chicago report. Amneal launches Fylnetra biosimilar Fylnetra is used to treat neutropenia, which is commonly experienced by patients undergoing chemotherapy. U.S. Supreme Court rejects Teva challenge to $235M GSK award in patent dispute over generic drugs involving Coreg The case involves "skinny labels," which allow generic drugmakers to avoid patent lawsuits if a generic drug's label omits potentially infringing uses of a brand-name drug, per a Reuters report. Aurigene Pharmaceutical Services expands biologics CDMO capacity Aurigene is investing $40 million in an R&D and pilot scale facility as a first step toward a series of strategic investments. First Previous 43 44 45 46 47 Next Last
